Pursuant to Regulation 39(3) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 (‘Listing Regulations’), Aarti Drugs has informed that the Company has received information from Link Intime India, Registrar & Share Transfer Agent of the Company for Loss of share certificates, details of which is enclosed. The duplicate share certificates will be issued only after compliance of required formalities in this regard.
The above information is a part of company’s filings submitted to BSE.
